DESONEX desloratadine 5 mg tablet film coated blister pack

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

desloratadine, Quantity: 5 mg

Disponível em:

Bayer Australia Ltd

Forma farmacêutica:

Tablet, film coated

Composição:

Excipient Ingredients: maize starch; purified water; Carnauba Wax; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; purified talc; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; macrogol 400

Via de administração:

Oral

Unidades em pacote:

2,3,5,7,10,14,15,20,25,28,30,42,45,50,60, 4, 1 tablet (sample pack), 40

Tipo de prescrição:

(S2) Pharmacy Medicine

Indicações terapêuticas:

The rapid relief of symptoms associated with seasonal allergic rhinitis. The nasal symptoms of allergic rhinitis include rhinorrhoea, sneezing and nasal,itching. Allergic rhinitis is also associated with non-nasal symptoms such as ocular itching, tearing and itching of the eyes or palate., The relief of,symptoms associated with perennial allergic rhinitis. The symptomatic relief of itching and reduction in the size and number of hives associated with,chronic idiopathic urticaria.

Resumo do produto:

Visual Identification: Light blue round, central circular debossed on one side of the tablet, plain on the other side, film-coated tablets; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status de autorização:

Registered

Data de autorização:

2021-01-05